COMPARISON OF CLINICAL OUTCOME OF AUTOINOCULATION VS ACITRETIN IN PATIENTS WITH VIRAL WARTS AT TERTIARY CARE HOSPITAL, KARACHI

Main Article Content

Muhammad Khurram
Rabia Ghafoor
Misbah Zari Qadir
Kanwal Phulpoto
Soonha Iqra
Nazia Jabeen
Ashraf Hussain
Khadija Asadullah

Keywords

Viral Warts, Autoinoculation, Acitretin, clinical outcomes

Abstract

Background: Viral warts are benign growths on the skin, mucous membranes, and other epithelial tissues caused by various strains of the human papillomavirus (HPV). Autoinoculation and acitretin have shown efficacy in treating multiple viral warts by increasing the immune response and reducing wart’s proliferation. Autoinoculation stimulates the body's defense mechanisms whereas Acitretin acts as a systemic retinoid to promote skin regeneration and reduce wart recurrence.


Objective: The present study aimed to compare the clinical outcome of autoinoculation vs acitretin in viral warts patients, at tertiary care hospital, Karachi.


Study Design: Randomized controlled trial


Materials and Methods: This randomized controlled trial investigated 40 viral warts patients in the Dermatology Department of Tertiary Care Hospital, Karachi from March 2024 to August 2024. Eligible participants were randomly assigned to one of the two treatment groups: Group A (Autoinoculation therapy; n =20) and Group B (Acitretin therapy; n=20). Patients in Group A (Autoinoculation therapy) were received autoinoculation therapy. Group B patients administrated with Oral acitretin 0.5 mg/kg body weight/day for a total duration of three months. Efficacy of Autoinoculation and Acitretin therapy measured in terms of complete, partial, and no response. SPSS version 23 was used for data analysis.


Results: Mean age of patients was 27.25 ± 10.32 years. The mean duration of warts disease was 8.78 ± 6.24 months. Cosmetic disfigurement, Itching, and Pain was the most prevalent symptoms of warts. Among 40 warts cases, the common warts were the prevalent type of warts found in 29 (72.5%) followed by Plantar 8 (20%) and plane 3 (7.5%). Regarding the site of wart, hand was the most common site 21 (52.5%) followed by feet 14 (35%). The incidence of complete, partial, and no response in Group A vs. Group B was 5 (25%) vs. 3 (15%), 13 (65%) vs. 11 (55%), and 2 (10%) vs. 6 (30%), respectively. There was no statistical significance regarding side effects in both groups.


Conclusions: This study shows that autoinoculation is a promising treatment for viral warts, resulting in better clinical outcomes and patient satisfaction compared to acitretin.  Autoinoculation is considered as one of the effective and safe treatment of viral warts.

Abstract 120 | Pdf Downloads 61

References

1. Shahid MW, Iftikhar N, Irshad M, Akhtar A, Hafeez J, Ali UA. Efficacy of Autoinoculation in Treatment of Multiple Viral Warts - A Single Arm Study. J Coll Physicians Surg Pak 2023; 33(02):141-144.
2. Shi L, Luo M, Zhang F, Zhang L, Wang B, Liu P, Zhang Y, Zhang H, Yang D, Zhang G, Zhou F. Photothermal therapy enhanced the effectiveness of imiquimod against refractory cutaneous warts through boosting immune responses. J Biophotonics 2019; 12(2):e201800149. doi: 10.1002/jbio.201800149
3. Mousa HA. Autoinoculation Therapy for the Treatment of Widespread Cutaneous Warts. Dermatologic Surgery. 2024 Apr 1;50(4):341-4.
4. Brown M, Williams A, Chilcott RP, Brady B, Lenn J, Evans C, Allen L, McAuley WA, Beebeejaun M, Haslinger J, Beuttel C. Topically Applied therapies for the treatment of skin disease: Past Present and Future. Pharmacological Reviews. 2024:Pharmacol-Rev.
5. Van Doorslaer K, Li Z, Maes P et al. (2017): The papillomavirus Episteme: a major update to the papillomavirus sequence database. Nucleic Acids Res., 45:499-506.
6. Lindeman J, Guimera N, Lioveras B et al. (2013): The occasional role of low-risk human papillomavirus 6, 11, 42, 44 and 70 in anogenital carcinoma defined by laser capture microdissection/PCR methodology, results from a global study. Am J Surg Pathol., 37(9):1299-1310.
7. Faleiro KN, Shukla P. Role of autoinoculation in the management of cutaneous warts: A comparison study with 100% tricholoroacetic acid application. Int J Res Dermatology 2020;6(4):537 doi: 10.18203/issn.2455-4529.intjresdermatol20.
8. Khatu S, More Y, Vankawala D, Pawar S, Gokhale N, Chavan D. Treating multiple and recalcitrant wart with autoimplantation technique. J Dr NTR Univ Heal Sci 2017; 6(4):247 doi:10.4103/2277-8632.221528.
9. Taneja G, Hazarika N, Bhatia R. Effectiveness of autoinoculation in viral warts: A single arm, open-label, and clinical trial. Dermatol Ther 2020; 33(6):e14122 doi: 10.1111/dth.14122.
10. Naheed, Asghar M, Rehman N, Afridi IU, Khalid S. Epidemiological and clinical patterns of viral warts presenting to dermatology OPD of Hayatabad Medical Complex, Peshawar. J Pakistan Assoc Dermatologists 2022; 32(1): 78-84.
11. Gopal V, Shenoy MM and Pinto M. Common warts revisited: a clinical study. International Journal of Research in Dermatology. 2017; 3: 261-6.
12. Witchey DJ, Witchey NB, Roth-Kauffman MM and Kauffman MK. Plantar warts: epidemiology, pathophysiology, and clinical management. J Am Osteopath Assoc. 2018; 118: 92-105.
13. Omar MA, Nofal A, Balat A, Mohamed W. Role of Acitretin in Management of Multiple Warts. The Egyptian Journal of Hospital Medicine. 2022 Apr 1;87(1):1153-6.
14. Nofal A, Fawzy MM, Eldeeb F, Elhawary EE. Oral isotretinoin versus acitretin in male patients with multiple recalcitrant common warts: A randomized, double‐blinded placebo‐control study. Journal of Cosmetic Dermatology. 2022 Nov;21(11):5895-901.1-8.
15. Shin DS, Han SS, Kim TL, Jang JW, Seo HM, Kim JS. Treatment of recalcitrant viral warts with combination therapy of systemic acitretin and diphenylcyclopropenone immunotherapy. Annals of Dermatology. 2020 Jun;32(3):243.
16. Nofal AA. Evaluation of acitretin versus oral isotretinoin in the treatment of common warts. Zagazig University Medical Journal. 2023 Mar 1;29(2):417-24.
17. Rijsbergen M, der Kolk NT, Hogendoorn G, Kouwenhoven S, Lemoine C, Klaassen ES, et al. A randomized controlled proof of concept trial of digoxin and furosemide in adults with cutaneous warts. Br J Dermatol 2019; 180(5):1058-68. doi:10.1111/bjd.17583.
18. Fasih S, Arif AB, Younas S. Pattern of skin diseases in Abbas Institute of Medical Sciences, Muzaffarabad. Pak J Physiol 2017; 13(4):26-9 http://pjp.pps.org.pk/index.php/ PJP/article/view/284.
19. Abeck D, Tetsch L, Lüftl M, Biedermann T. Extragenital cutaneous warts: Clinical presentation, diagnosis and treatment. J Dtsch Dermatol Ges 2019; 17(6):613-34. doi: 10.1111/ddg.13878.
20. Arshad A, Younas S, Ahmed TJ, Rashid T, Nadeem M. Outcome of 20% topical zinc oxide ointment in the treatment of cutaneous warts of hands and feet. J Fatima Jinnah Med University 2019; 13:23-5.
21. Gulanikar AD, Bhide DS, Pethe SA. Autoimplantation therapy for recalcitrant viral warts. Clin Dermatol Rev 2018; 2(2):74-7. doi: 10.4103/CDR.CDR_12_17.
22. Narayanan S, Nallu K, Venu S, Chandrasekar M. A prospective clinical study on homologous autoinoculation in anogenital wart. Int J Res Dermatol 2019; 5(2):325-8. doi:10.18203/issn.2455-4529.IntResDermatol20190984.

Most read articles by the same author(s)